What is Careprost?
Careprost is generic Latisse and contains Bimatoprost Ophthalmic Solution. This medication is the only proven method of treating hypotrichosis (inadequately short eyelashes) by increasing the length, thickness, darkness, and quantity of eyelashes when applied on the lash line of the upper eyelid base. Bimatoprost Opthalmic Solution is also used to treat glaucoma by increasing the movement of fluid out of the eye, resulting in less pressure (however, the medication is dropped inside of the eye to treat glaucoma).
How Careprost works:
Careprost helps eyelashes grow by increasing the number of hairs in the initial growth phase (the anagen phase). It also increases the amount of time hairs remain in the anagen phase, allowing them to develop more.
How to use Careprost to increase lash length:
- Apply one drop of Careprost on a disposable eyeliner applicator brush and draw along the upper eyelid lash line. Carefully blot off any excess that may have dripped beyond the upper eyelid. Do not apply to the lower lash line. Repeat for the other eye.
- Apply once a day until the desired length is achieved. Results are usually apparent in about eight weeks, and the desired length is usually achieved in 14 to 16 weeks.
- Once the desired length is achieved, maintain the new lashes by applying Careprost once a week. The once-a-week treatment is necessary for maintaining the new length because after use is discontinued, eyelashes will revert back to their normal growth patterns.
Possible side effects: dryness visual disturbance eye pain burning sensation foreign body sensation ocular irritation tearing eyelash darkening conjunctival edema eye discharge allergic conjunctivitis increases in iris pigmentation
Precautions Bimatoprost Ophthalmic Solution has been reported to cause changes to pigmented tissues. These reports increased pigmentation and growth of eyelashes and increased pigmentation of the iris and periorbital tissue (eyelid). These changes may be permanent. Careprost may gradually change eye color, increasing the amount of brown pigment in the iris by increasing the number of melanosomes (pigment granules) in melanocytes. The long-term effects on the melanocytes and the consequences of potential injury to the melanocytes and /or deposition of pigment granules to other areas of the eye are currently unknown. The change in iris color occurs slowly and may not be noticeable for several months to years.